Mani Mohindru insider trades

Open-market stock purchases and sales by Mani Mohindru, Chief Executive Officer at Cardiff Oncology, Inc, from SEC Form 4 filings since Jan 19, 2016.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -30%.

Recent trades

DateStockTradeValue
Jul 14, 2026CRDF Cardiff Oncology, IncBought$50K
Jul 14, 2026CRDF Cardiff Oncology, IncBought—
Jun 18, 2026CRDF Cardiff Oncology, IncBought$29.9K
Jun 17, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Mar 31, 2026CRDF Cardiff Oncology, IncBought (not open market)—
Feb 17, 2026CRDF Cardiff Oncology, IncBought (not open market)—

Companies traded

  • CRDF Cardiff Oncology, Inc: 3 buys, last Jul 14, 2026
  • CTMX CytomX Therapeutics, Inc: other filings, last Jun 17, 2026
  • CARA Cara Therapeutics, Inc: 7 sales, last Dec 4, 2019
  • CRIS Curis Inc: other filings, last Feb 14, 2017

Get free alerts when Mani Mohindru files a new trade →